Hypotensive epidural anesthesia in pa- tients with aortic stenosis undergoing total hip replacement. Reg Anesth Pain Med. 2008;33:129 33. 15. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521 643. 16. Mittnacht AJ, Fanshawe M, Konstadt S. Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery. Semin Cardiothorac Vasc Anesth. 2008;12:33 59. 17. Frogel J, Galusca D. Anesthetic considerations for patients with advanced valvular heart disease undergoing noncardiac surgery. Anesthesiol Clin. 2010;28:67 85. 18. Smilowitz NR, Armanious A, Bangalore S, et al. Cardiovascular outcomes of patients with pulmonary hypertension undergoing noncardiac surgery. Am J Cardiol. 2019;123:1532 7. 16. EVIDENCE GAPS AND FUTURE DIRECTIONS 16.1. Prevention of Valve Disease: Stage A 1. Nazarzadeh M, Pinho-Gomes A-C, Smith Byrne K, et al. Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study. JAMA Cardiol. 2019;4:788 95. 2. Lindman BR, Clavel M-A, Mathieu P, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006. 3. Lindman BR. Aortic stenosis: moving from treatment to prevention. J Am Coll Cardiol. 2017;69:1533 5. CLINICAL STATEMENTS AND GUIDELINES 4. Atkins SK, Aikawa E. Valve under the microscope: shining a light on emerging technologies elucidating disease mechanisms. Heart. 2019;105:1610 1. 5. Peeters FECM, Meex SJR, Dweck MR, et al. Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment. Eur Heart J. 2018;39:2618 24. 6. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med. 2007;357:439 41. 7. Soler-Soler J, Galve E. Worldwide perspective of valve disease. Heart. 2000;83:721 5. 8. Nkomo VT, Gardin JM, Skelton TN, et al. 